Clinical Trials Logo

Radiation Injury clinical trials

View clinical trials related to Radiation Injury.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02725840 Active, not recruiting - Breast Cancer Clinical Trials

Breast Cancer Lung Late Effects

BELLE
Start date: May 2016
Phase:
Study type: Observational

Through improved early detection and treatment, the number of long term breast cancer survivors continues to increase. There are now 2.8 million breast cancer survivors in the U.S. Florida alone adds over 9,000 women to the survivorship pool each year. Most receive radiation treatment (RT) of the affected breast and chest wall to reduce risk of recurrence. Even with advanced radiation techniques for dose conformality to minimize exposure of the highly sensitive lung, 14% of breast cancer patients treated with radiation develop clinical pulmonary toxicity, with 4% overall experiencing high grade clinical toxicity. Early diagnosis and intervention to mitigate lung radiation toxicity is increasingly important for the long term care of these survivors. The investigators' goal is to better identify breast cancer patients at high risk for experiencing severe pulmonary toxicity requiring medical intervention, provide a means to identify toxicity early on, and tailor treatment and/or early intervention on a per-patient basis.